相关实验视频

Updated: Jun 10, 2025

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
08:34

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

Published on: February 24, 2021

2.4K

富血小板血用于治疗女性压力尿失禁

Amirhossein Pourebrahimi1, Anita Khalili1, Saleh Behzadi2

  • 1Department of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

International urology and nephrology
|October 10, 2024
PubMed
概括

富血小板血 (PRP) 注射显示为对压力尿失禁 (SUI) 妇女的安全和有效治疗的承诺,这些妇女对传统疗法没有反应. 这种最少的侵入性选择可以改善症状,并可能比手术更快地恢复.

关键词:
一个女人,一个女人.富含血小板血的血含量是多少再生医学是一种再生医学.压力性尿失禁是压力性尿失禁.

更多相关视频

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial08:14

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

12.9K
Injection of Porcine Adipose Tissue-Derived Stroma Cells via Waterjet Technology07:05

Injection of Porcine Adipose Tissue-Derived Stroma Cells via Waterjet Technology

Published on: November 23, 2021

1.8K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
155